23rd Annual SoCalBio Conference

24th Annual SoCalBio Conference

October 6, 2022 – October 7, 2022

Westin Long Beach

www.socalbioinvest.com

Purpose

The SoCalBio Conference is an annual event organized by the Southern California Biomedical Council (SoCalBio). This conference is preceded by a CEO Reception & Dinner on October 6 which will feature keynote presentations by distinguished speakers. The SoCalBio conference showcases Southern California value-based bioscience innovations and explores efficient pathways to bring them to market. In addition to plenary sessions, business roundtables and therapeutic workshops, this conference will feature at least 40 company presentations showcasing the strength and future of the bioscience industry in Los Angeles/Orange County and neighboring communities.

Who Attend

  • Biotech, Pharma, IVD, Informatics and Medical Device Company Executives
  • Venture Capitalists
  • Angel Investors
  • Investment Bankers
  • Life-Science Educators and Researchers
  • Service Providers
  • Policy Makers and Economic Development Professionals
  • Media Representatives

Agenda

Day 1, October 6, 2022

1:00 PM Registration Start
1:00 PM – 5:00 PM Setting up Exhibits
5:00 PM Cocktail Reception, Networking, Visit Exhibits
6:00 PM Sit-Down Dinner
7:00 PM Teconomy Presentation : The 2022 State of the Bioscience Industry in Greater Los Angeles
7:45 PM Panel Discussion: What is New in Supporting Industry Growth in the Greater Los Angeles Metro Region: Sorting the Signals from Noise Real Estate – Funding – Technical Services – Incubators – Talent Acquisition – Tech Transfer
8:30 PM Day one adjournment

Day 2, October 7, 2022

7:00 AM Breakfast & Sponsor Display Set up
8:30 AM SoCalBio Introductions and Sponsor Recognition
8:45 AM Acknowledging the SoCalBio Innovation Catalysts
9:00 AM Keynote Presentations: The Biology/Engineering Conversion and the Rise of Integrative Biology
  • A Biotech Perspective by Phil Tagari , PhD , VP of Research, Amgen
  • A MedTech Perspective by Robert Greenberg, MD, PhD , Chair, Alfred Mann Foundation for Biomedical Enginering
10:00 AM Break
10:15 AM The Promise of Integrative Biology/Multi Omics Paradigm
  • Enabling Precision Medicine: A Panel Discussion by the Terasaki Institute
11:15 AM Precision Medicine:
  • The Journey from Science To Value
12:00 PM Lunch
Technologies Frontier Business Trends Emerging Co. Presentations
1:00 PM The Hunt for Biomarkers: Enabling post genomic personalized medicine, and emerging technology governance to move systems science into clinical practice Keynote Presentation:
  • Kara Bortone, PhD, Sr. Director, Diagnostics & Enabling Technologies, Janssen Business Development at Johnson & Johnson
Panelists:
  • James Berenson, MD, President, ONCOtracker , Inc
  • Robert Terbrueggen , PhD, President & CEO, DxTerity Diagnostics
  • Hsian Rong Tseng, Ph.D. D., Founder, Eximius
Funding Trends: Who is Getting Money and Why in the Current Market? Keynote Presentation:
  • Milo Bissin , Director, Silicon Valley Bank
Panelists:
  • Wavemaker 360
  • Vida Ventures
  • Bold Capital
  • Tech Coast Angels
  • Keiretsu SoCal
  • Section 32
5 Emerging Companies
2:00 PM Biometrics and Computational Technologies in Cancer Treatment How AI Helps in Predicting and Managing Cancer Drugs’ Adverse Events Keynote Presentation:
  • John Shon, Chief Technology Officer, SerImmune Inc.
Panelists:
  • TBA
Strategic Options for Emerging Companies: Partnering Strategies in the Current Tight Funding Environment Panelists:
  • Sanjay Mistry, Vice President Johnson & Johnson Innovation
  • Kanad Das, Investment Director, Boehringer Ingelheim Venture Fund
  • Amgen
  • Michael Martin, PhD, Global Head of Takeda Ventures
  • Medtronic
5 Emerging Companies
3:00 PM Coffee & Cookies Break
3:15 PM Smart Surgery: A New Area in Surgical Technologies that Enable Precision MedTech Care Keynote Presenter:
  • Jean Pierre Hubschman , MD, Founder, Horizon Surgical Devices
Panelists:
  • J&J
  • Others TBA
Los Angeles Area Incubators: Are they Really Serving the Local Economy? What Are the Metrics to Assess Performance? Moderator:
  • Christopher Buser , PhD, Oak Crest Institute
Panelists:
  • Jamey Edwards, COO, Startup Health
  • Nick Mourlas , Head of JLABS San Diego
5 Emerging Companies
4:15 PM Enabling a Distributed Healthcare Regime: Precision Medicine in Homecare Through Remote, Medical Grade Monitoring with Wearables and Other Smart Devices Keynote Presenter:
  • Ruey Kang Chang, MD, MPH, CEO, QT Medical, Inc.
Panelists:
  • TBA
Talent Development: Will Double Majoring in Biology and Engineering Lead to Better Bioscience Industry Career Pathways? Moderator:
  • Christopher Buser , PhD, Oak Crest Institute
Panelists:
  • Song Li, PhD, Chair of Bioengineering, UCLA
  • Various Execs TBA
5 Emerging Companies
5:15 PM Closing Cocktail Reception with Awards to Company Presenters
7:00 PM Conference Adjourns

About SoCalBio

Southern California Biomedical Council (SoCalBio) is a nonprofit, member-supported trade association that serves the biotech, medtech, IVD and digital health communities in the six counties that comprise the Greater Los Angeles region (Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino).  Find information about SoCalBio at: www.socalbio.org.

Oppenheimer Tower, 10880 Wilshire Blvd., Suite 1101,
Los Angeles, CA 90024

800-418-7079 – scbc@socalbio.org

Thanks to Lead Sponsors